Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Avatrombopag for the Treatment of Chemotherapy-Induced Thrombocytopenia in Adults With Active Non-Hematological Cancers

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT03471078
Recruitment Status : Active, not recruiting
First Posted : March 20, 2018
Last Update Posted : February 15, 2021
Sponsor:
Information provided by (Responsible Party):
Dova Pharmaceuticals

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Active, not recruiting
Actual Primary Completion Date : August 28, 2020
Estimated Study Completion Date : August 2025